Lincoln Pharmaceuticals Ltd achieves the milestone of Profit Growth Every Single year from FY13 to FY23

Ahmedabad: Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has achieved the milestone of reporting a profit growth every single year from FY13 to FY23. It is among only 16 companies out of 4,200 plus listed companies in the Indian stock exchange to do so as per the analysis of Morningstar.

Financial Overview - Lincoln Pharmaceuticals FY 13 to FY23

Year	Revenue	EBITDA	Net Profit	EPS
FY 23	532.79	111.65	72.90	36.40
FY 13	192.96	18.58	9.81	6.02
10 Yrs CAGR	10.69%	19.64%	22.21%

Figure in Rs cr except EPS

During 10 years from FY13 to FY23, Company has delivered a robust CAGR of over 22% in Net profits, 19% plus in EBITDA and over 10% in Revenue. The liquidity position of the company is on a strong foundation, supported by healthy cash accruals, no-term debt, and healthy return ratios. Backed by improvement in the company’s financial risk profile, steady growth in scale & margins, healthy profitability, rating agency ICRA has upgraded the company’s long-term and short-term bank facilities to A and A1 respectively.

For FY23, company has reported its Best-ever results in a financial year with highest - Revenue, EBITDA and Net Profit. Company achieved milestone of Rs. 500 crore plus revenue and Rs. 100 crore plus profit before tax for the first time in a financial year.

Morningstar is a US-based investment research firm that compiles and analyzes fund, stock, and general market data. The firm recently published a story ‘Companies that have shown consistent profit growth’ based on data points of Ms. Devina Mehra, Founder & CMD, First Global that, over the past 10 years, if you look at the 4,200-odd listed companies in India, how many of them have shown profit growth every single year? Just 16! Just 0.4%! Over the past 20 years, if you look at all the listed companies in India, only 1 company – HDFC Bank have shown some profit growth every single year.

Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Limited, said, “We are very happy and excited to know that Lincoln Pharma has been able to achieve profit growth every single year over the last 10 years and among a very few companies to do so. Company is growing from strength-to-strength over the years and expects to maintain the growth in years to come. Strategic growth initiatives, product and geographical expansion, and operational efficiency are likely to contribute to growth going forward. Company has set a target of achieving Rs. 750 crore revenue by FY26 while maintaining or improving its margins.”

Lincoln Pharma Profits for the last 10 years

Financial Year	Net Profit (Rs. cr)
FY 2023	72.90
FY 2022	69.36
FY 2021	60.41
FY 2020	49.56
FY 2019	46.64
FY 2018	34.65
FY 2017	27.08
FY 2016	23.80
FY 2015	14.77
FY 2014	11.42
FY 2013	9.81

Lincoln Pharma has a state-of-the-art manufacturing facility unit at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by EUGMP, WHO-GMP and ISO-9001: 2015. Company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, ant-diabetic, anti-malaria among others. Company has filed 25 plus patent applications and is awarded with seven patents. Company has a strong presence in the domestic market nationally with a dedicated field force of over 600 personnel who cater to more than 30,000 doctors, chemists across the country.

Providing Affordable and Innovative medicines for healthier lives.

Lincoln Pharmaceuticals Limited is one of the leading healthcare companies in Gujarat, India. Established in the year 1979, the company develops and manufactures affordable and innovative medicines for healthier lives. The company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, anti-diabetic, anti-malaria among others. Company has over 1,700 registered products and another 700 in pipeline. The company has its strong presence in Domestic market with good strength of own field force and also exports to more than 60 Countries.

Company has developed many new drug delivery dosage forms over years and has a track record of launching many first-of-its-kind innovative products. Company works with vision for nurturing innovations and bringing them to Indian patients at affordable cost to create “Healthcare for All”.

 

Lincoln Pharma has two state-of-the-art manufacturing facility units at Khatraj in Ahmedabad and Mehsana, Gujarat. Company’s manufacturing facilities comply with stringent international quality and compliance norms and certified by EU-GMP, WHO-GMP, TGA - Australia and ISO-9001:2015. Company is engaged in manufacturing of pharma formulations like Tablets, Capsules, Injectables, Syrups, Ointments, etc.

 

Company's key strength is embedded in its cutting-edge research and development capabilities. The company has a strong R&D team including 30 plus scientists. It has filled 25 plus patent applications and is awarded seven patents. R&D facility of the company is recognised by the Department of Scientific and Technology, Government of India and furnished with state-of-the-art devices and equipment for internal physical, chemical and microbiological analysis of all products.

 

Company has a strong presence in the domestic market nationally with a dedicated field force of over 600 personnel who cater to more than 30,000 doctors, chemists across the country. Company has a wide national distribution network through 21+ Super Stockist and over 50,000 retailers in 26 states across India.

 

Going green, company has also set up a new Solar Plant of 1 MW at factory’s rooftop in addition to two windmills. This way we are producing renewable energy to our consumption nearly 65% resulting significant saving in the electricity cost and helped the company to become a self-sustainable and environment-friendly organization.